Trial Profile
Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early Diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms RELEASE
- 15 Sep 2017 Results assessing effect of linagliptin on plasma levels of nitrate in parallel with the reduction in FDG-PET-assessed arterial inflammation by comparing patients from this trial and young healthy controls, presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes.
- 15 Sep 2017 Results (n=44) assessing association between visceral adipose tissue volume and subclinical arterial inflammation presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes